HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Compelled To Test ‘Natural’ Climate But Hedges On Rulemaking Forecast

This article was originally published in The Tan Sheet

Executive Summary

FDA notes three citizen petitions asking the agency to define “natural” for use in food labeling and one asking it to prohibit the term on labels in addition to federal courts requesting administrative determinations,. But a rulemaking might not be the outcome, and any decision will be a long time in coming.

You may also be interested in...



J&J’s Zarbee’s Natural Business Stung By P&G Challenge To Using ‘Natural’ In Brand Name

NAD recommends qualifying Zarbee’s Naturals brand on packaging when a formulation contains synthetic ingredients. J&J business will comply but disagrees its brand is misleading and says the recommendation is “not based on empirical data from consumers surveys” but NAD attorneys’ intuition.

COVID-19 Deter Class Actions? No. Plaintiffs' Attorneys Have Time For More Complaints? Yes.

Class action complaints filed in 2020 against food, dietary supplement and beverage firms should pass 2019’s total as COVID-19 has not slowed litigants but has given plaintiffs’ council more time out of court to shop for new cases.

GSK Appeals Industry Self-Regulation Forum’s Finding Against Benefiber ‘100% Natural’ Claim

GSK will appeal a finding that it doesn’t support its “100% Natural” claim for Benefiber Original and Healthy Shape. Question asked in the review from a P&G challenge reflects FDA’s ongoing consideration of whether a public health concern will emerge if it doesn’t substantially expand its regulation of use of the term.

Related Content

Topics

UsernamePublicRestriction

Register

OM004078

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel